Pediatric Clinical Trials - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study of Abemaciclib, Irinotecan, and Temozolomide for Patients with Relapsed or Refractory Ewing’s Sarcoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Ewing’s sarcoma
Investigated Drugs:
Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1
Investigated Drugs:
- Guselkumab
+2
Study of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Not recruiting

3 1 1 1
Investigated Diseases:
- Uveitis
Investigated Drugs:
- Adalimumab
- Baricitinib
Study on the Effectiveness and Safety of Obinutuzumab and Mycophenolate Mofetil in Children with Idiopathic Nephrotic Syndrome

Not recruiting

3 1 1 1
Investigated Drugs:
- Mycophenolate Mofetil
- Obinutuzumab
Study on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome

Not recruiting

2 1
Investigated Drugs:
- Gemlapodect
Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

Not recruiting

3 1 1 1
Investigated Diseases:
- Haemophilia A without inhibitors
Investigated Drugs:
- Emicizumab
Study on the Effects and Safety of INZ-701 for Children with ENPP1 Deficiency

Not recruiting

3 1 1
Investigated Drugs:
- Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Not recruiting

3 1 1
Investigated Diseases:
- Thrombotic microangiopathy
Investigated Drugs:
- Ravulizumab
+3
Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Not recruiting

3 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
+6
Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

Not recruiting

3 1 1 1
Investigated Diseases:
- Primary immunodeficiency syndrome
Investigated Drugs:
- Hyaluronidase (Human Recombinant)
- Human Normal Immunoglobulin
+2

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies